Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1661, 2008-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Natalizumab shows clinical, cost and QOL benefits
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 514, 2006-01 ,pp. :
Access to resources
Recommend
Natalizumab benefits QOL in multiple sclerosis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 577, 2009-01 ,pp. :
Simvastatin shows major benefits in diabetes
Inpharma, Vol. 1, Iss. 1392, 2003-01 ,pp. :
Oxandrolone shows benefits in muscular dystrophy
Inpharma, Vol. 1, Iss. 1292, 2001-01 ,pp. :
QOL benefits with palliative chemotherapy in ovarian cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 307, 2001-01 ,pp. :